The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
One partner. Every phase. Visit booth 6A2 at CPHI Milan 2026 to streamline drug development.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Small Pharma, Big Opportunity: Should CDMO Partner Size Influence Selection for your Large Molecule Project?
Infographic
Overview: With resource constraints and process development challenges within early development, new & emerging companies are often left with the difficult decision on whether to select a small or large CDMO for their steriles drug product. This critical decision not only has implications within early development , but also with scale-up and commercialization.